998 resultados para pharmaceutical R
Resumo:
[Euchologe (français). 1933-1939 fac-sim.]
Resumo:
[Euchologe (français). 1933-1939 fac-sim.]
Resumo:
Over the last two decades, thanks to the discovery of several pharmaceutical agents, multiple sclerosis (MS) has been transformed into a treatable disorder although the degree of therapeutic response may vary considerably. As more medications find their entry into the MS market, a clinician faces a mounting challenge of comparing risk and benefit profiles of various agents in an attempt to find the best treatment approach for each individual patient. In this review, we aim to summarize the available data on safety profiles of available MS therapies while focusing mostly on serious medication specific potential adverse events without discussing the teratogenic potential of each agent (unless there is a black box warning) or hypersensitivity reactions. Our goal is to provide a clinician with guidance on assuring the appropriate safety monitoring for patients treated with one of the agents discussed. We also comment on the future of risk management in MS and discuss possible enhancements to the current model of drug approval process and general strategies to improve the patient safety.
Resumo:
Este proyecto final de carrera, consiste en la creación de un blog que gira en torno de una misma temática: el P.I.R (Psicólogo interno residente). Este título se crea en diciembre de 1998 mediante el Real Decreto 2490/1998. Se obtiene realizando la formación especializada en una plaza sanitaria de psicólogo interno residente o por un proceso de solicitud, de acuerdo con lo previsto en las disposiciones transitorias, para quienes ejercen antes de la creación del mismo.
Resumo:
En aquest projecte es vol implementar una llibreria en Java, que proporcioni leseines necessàries per a crear diagrames i esquemes. Es vol proporcionar a la llibreria unconjunt d’objectes bàsics, també mètodes i funcionalitats suficients per a gestionaraquests objectes. Per altra part, es vol implementar una aplicació per a dissenyar diagrames Entitat-Relació que utilitzi aquesta llibreria
Resumo:
This paper studies how the strength of intellectual property rights (IPRs) affects investments in biological innovations when the value of an innovation is stochastically reduced to zero because of the evolution of pest resistance. We frame the problem as a research and development (R&D) investment game in a duopoly model of sequential innovation. We characterize the incentives to invest in R&D under two competing IPR regimes, which differ in their treatment of the follow-on innovations that become necessary because of pest adaptation. Depending on the magnitude of the R&D cost, ex ante firms might prefer an intellectual property regime with or without a “research exemption” provision. The study of the welfare function that also accounts for benefit spillovers to consumers—which is possible analytically under some parametric conditions, and numerically otherwise—shows that the ranking of the two IPR regimes depends critically on the extent of the R&D cost.
Resumo:
Kirje 18.11.1975